Villeurbanne, France

François Mallet

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Journey of François Mallet

Introduction

François Mallet, an accomplished inventor based in Villeurbanne, France, has made significant strides in the field of immunology and oncology. With a portfolio of eight patents, Mallet has contributed innovative methods and tools aimed at enhancing medical diagnostics and treatments.

Latest Patents

Among his most recent inventions is a groundbreaking method for determining, in vitro or ex vivo, the immune status of an individual. This method detects and quantifies the expression of one or more Human Endogenous Retrovirus (HERV)/Mammalian Leukemia Virus-Related (MaLR) sequences in a biological sample obtained from the individual. Additionally, he has developed a patent for an in vitro method for the diagnosis or prognosis of lung cancer. This method involves detecting at least one expression product of a HERV nucleic acid sequence, identifying these molecular markers for use in diagnostic kits.

Career Highlights

Mallet has built a notable career, notably working with Biomerieux, Inc. and Hospices Civils De Lyon. His engagement in these esteemed organizations has allowed him to further his research and push the boundaries of existing medical technologies.

Collaborations

Throughout his career, Mallet has collaborated with notable colleagues, including Philippe Perot and Nathalie Mugnier. These partnerships have fostered an environment of innovation and creativity, essential for the development of cutting-edge medical tools.

Conclusion

François Mallet exemplifies the spirit of innovation and invention. With a focus on advancing medical diagnostics through his patented methods, he continues to pave the way for future developments in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…